47.443275, 7.732506
Bachem
Bubendorf, Switzerland
- Verified lead
- Anne-Kathrin Stoller
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Peptide API Manufacturing, Oligonucleotides, and GMP Supply
- Review cycle
- May 2026
- Full address
- Hauptstrasse 144, CH-4416 Bubendorf, Switzerland
- Site coordinates
- 47.443275, 7.732506
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Bachem executive committee page confirming Anne-Kathrin Stoller as CEO.
- Editorial note
- Bubendorf peptide-manufacturing campus with large-scale synthesis expansion, quality control, and site-management-linked production infrastructure.
Peptide API Manufacturing, Oligonucleotides, and GMP Supply
GMP peptide manufacturing, Global quality systems
Bubendorf peptide-manufacturing campus with large-scale synthesis expansion, quality control, and site-management-linked production infrastructure.

Bachem
Peptide API Manufacturing, Oligonucleotides, and GMP Supply · Global GMP manufacturing
Bubendorf peptide-manufacturing campus with large-scale synthesis expansion, quality control, and site-management-linked production infrastructure.
- Lead
- Anne-Kathrin Stoller (verified ↗)
- Address
- Hauptstrasse 144, CH-4416 Bubendorf, Switzerland (source ↗)
- Compliance
- GMP peptide manufacturing
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global GMP manufacturing
- Capabilities
- Peptide APIs · Oligonucleotide Manufacturing · Commercial GMP Supply
- Founded
- 1971
- Headcount
- 1001-5000
- Company page (open ↗)

Anne-Kathrin Stoller
Chief Executive Officer
Global GMP manufacturing
Bubendorf, Switzerland. Peptide API Manufacturing, Oligonucleotides, and GMP Supply. Review completed on 14 Mar 2026.
Swiss, EU, and global pharmaceutical manufacturing oversight
GMP peptide manufacturing, Global quality systems
Peptide API Manufacturing, Oligonucleotides, and GMP Supply
Bubendorf peptide-manufacturing campus with large-scale synthesis expansion, quality control, and site-management-linked production infrastructure.
Bachem strengthens the Swiss supply spine with a 2026 CEO transition already live on the official executive committee page.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Bachem located?
- Bachem operates from Hauptstrasse 144, CH-4416 Bubendorf, Switzerland, Bubendorf, Switzerland.
- Who runs Bachem?
- Bachem is led by Anne-Kathrin Stoller, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Bachem hold?
- Bachem is documented under GMP peptide manufacturing.
- What does Bachem do?
- Bubendorf peptide-manufacturing campus with large-scale synthesis expansion, quality control, and site-management-linked production infrastructure. Core capabilities: Peptide APIs, Oligonucleotide Manufacturing, Commercial GMP Supply.
Related technical briefs
Briefs that name Bubendorf as a covered market or city.
